Alnylam Pharmaceuticals
ALNY
#446
Rank
A$78.92 B
Marketcap
A$597.40
Share price
-3.65%
Change (1 day)
55.28%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company